Cargando…

Use of Adjuvant Pharmacotherapy in Type 1 Diabetes: International Comparison of 49,996 Individuals in the Prospective Diabetes Follow-up and T1D Exchange Registries

Detalles Bibliográficos
Autores principales: Lyons, Sarah K., Hermann, Julia M., Miller, Kellee M., Hofer, Sabine E., Foster, Nicole C., Rami-Merhar, Birgit M., Aleppo, Grazia, Seufert, Jochen, DiMeglio, Linda A., Danne, Thomas, Maahs, David M., Holl, Reinhard W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463738/
https://www.ncbi.nlm.nih.gov/pubmed/28768688
http://dx.doi.org/10.2337/dc17-0403
_version_ 1783410805045198848
author Lyons, Sarah K.
Hermann, Julia M.
Miller, Kellee M.
Hofer, Sabine E.
Foster, Nicole C.
Rami-Merhar, Birgit M.
Aleppo, Grazia
Seufert, Jochen
DiMeglio, Linda A.
Danne, Thomas
Maahs, David M.
Holl, Reinhard W.
author_facet Lyons, Sarah K.
Hermann, Julia M.
Miller, Kellee M.
Hofer, Sabine E.
Foster, Nicole C.
Rami-Merhar, Birgit M.
Aleppo, Grazia
Seufert, Jochen
DiMeglio, Linda A.
Danne, Thomas
Maahs, David M.
Holl, Reinhard W.
author_sort Lyons, Sarah K.
collection PubMed
description
format Online
Article
Text
id pubmed-6463738
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-64637382019-04-26 Use of Adjuvant Pharmacotherapy in Type 1 Diabetes: International Comparison of 49,996 Individuals in the Prospective Diabetes Follow-up and T1D Exchange Registries Lyons, Sarah K. Hermann, Julia M. Miller, Kellee M. Hofer, Sabine E. Foster, Nicole C. Rami-Merhar, Birgit M. Aleppo, Grazia Seufert, Jochen DiMeglio, Linda A. Danne, Thomas Maahs, David M. Holl, Reinhard W. Diabetes Care e-Letters: Observations American Diabetes Association 2017-10 2017-08-02 /pmc/articles/PMC6463738/ /pubmed/28768688 http://dx.doi.org/10.2337/dc17-0403 Text en © 2017 by the American Diabetes Association. http://www.diabetesjournals.org/content/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.
spellingShingle e-Letters: Observations
Lyons, Sarah K.
Hermann, Julia M.
Miller, Kellee M.
Hofer, Sabine E.
Foster, Nicole C.
Rami-Merhar, Birgit M.
Aleppo, Grazia
Seufert, Jochen
DiMeglio, Linda A.
Danne, Thomas
Maahs, David M.
Holl, Reinhard W.
Use of Adjuvant Pharmacotherapy in Type 1 Diabetes: International Comparison of 49,996 Individuals in the Prospective Diabetes Follow-up and T1D Exchange Registries
title Use of Adjuvant Pharmacotherapy in Type 1 Diabetes: International Comparison of 49,996 Individuals in the Prospective Diabetes Follow-up and T1D Exchange Registries
title_full Use of Adjuvant Pharmacotherapy in Type 1 Diabetes: International Comparison of 49,996 Individuals in the Prospective Diabetes Follow-up and T1D Exchange Registries
title_fullStr Use of Adjuvant Pharmacotherapy in Type 1 Diabetes: International Comparison of 49,996 Individuals in the Prospective Diabetes Follow-up and T1D Exchange Registries
title_full_unstemmed Use of Adjuvant Pharmacotherapy in Type 1 Diabetes: International Comparison of 49,996 Individuals in the Prospective Diabetes Follow-up and T1D Exchange Registries
title_short Use of Adjuvant Pharmacotherapy in Type 1 Diabetes: International Comparison of 49,996 Individuals in the Prospective Diabetes Follow-up and T1D Exchange Registries
title_sort use of adjuvant pharmacotherapy in type 1 diabetes: international comparison of 49,996 individuals in the prospective diabetes follow-up and t1d exchange registries
topic e-Letters: Observations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463738/
https://www.ncbi.nlm.nih.gov/pubmed/28768688
http://dx.doi.org/10.2337/dc17-0403
work_keys_str_mv AT lyonssarahk useofadjuvantpharmacotherapyintype1diabetesinternationalcomparisonof49996individualsintheprospectivediabetesfollowupandt1dexchangeregistries
AT hermannjuliam useofadjuvantpharmacotherapyintype1diabetesinternationalcomparisonof49996individualsintheprospectivediabetesfollowupandt1dexchangeregistries
AT millerkelleem useofadjuvantpharmacotherapyintype1diabetesinternationalcomparisonof49996individualsintheprospectivediabetesfollowupandt1dexchangeregistries
AT hofersabinee useofadjuvantpharmacotherapyintype1diabetesinternationalcomparisonof49996individualsintheprospectivediabetesfollowupandt1dexchangeregistries
AT fosternicolec useofadjuvantpharmacotherapyintype1diabetesinternationalcomparisonof49996individualsintheprospectivediabetesfollowupandt1dexchangeregistries
AT ramimerharbirgitm useofadjuvantpharmacotherapyintype1diabetesinternationalcomparisonof49996individualsintheprospectivediabetesfollowupandt1dexchangeregistries
AT aleppograzia useofadjuvantpharmacotherapyintype1diabetesinternationalcomparisonof49996individualsintheprospectivediabetesfollowupandt1dexchangeregistries
AT seufertjochen useofadjuvantpharmacotherapyintype1diabetesinternationalcomparisonof49996individualsintheprospectivediabetesfollowupandt1dexchangeregistries
AT dimegliolindaa useofadjuvantpharmacotherapyintype1diabetesinternationalcomparisonof49996individualsintheprospectivediabetesfollowupandt1dexchangeregistries
AT dannethomas useofadjuvantpharmacotherapyintype1diabetesinternationalcomparisonof49996individualsintheprospectivediabetesfollowupandt1dexchangeregistries
AT maahsdavidm useofadjuvantpharmacotherapyintype1diabetesinternationalcomparisonof49996individualsintheprospectivediabetesfollowupandt1dexchangeregistries
AT hollreinhardw useofadjuvantpharmacotherapyintype1diabetesinternationalcomparisonof49996individualsintheprospectivediabetesfollowupandt1dexchangeregistries